“Blind faith” - it’s quite a dilemma I think for some shareholders - myself included. I seriously believe in the remote monitoring & the underlying product that supports it-and have since day dot. I haven’t sold a share in 3 years. It has such potential - and did even before COVID. However I have major reservations over the quality & integrity of management & their ability to achieve that potential. Their track record to date has been characterised by mid-step after mis-step & less than transparent behaviours. How do shareholders reconcile this? What a trade off.! The ASX delist - privatisation - list Nasdaq process requires the CEO & directors to do the “right thing” by all shareholders as their is limited recourse once delisted locally. I have a major concern about the comms / updates / transparency during the non-listed period which is why some sort of update should be a priority.
- Forums
- ASX - By Stock
- GMV
- Ann: G Medical seeks delisting to pursue Q4 NASDAQ listing
Ann: G Medical seeks delisting to pursue Q4 NASDAQ listing, page-572
-
- There are more pages in this discussion • 116 more messages in this thread...
You’re viewing a single post only. To view the entire thread just sign in or Join Now (FREE)
Featured News
Add GMV (ASX) to my watchlist
Currently unlisted public company.
The Watchlist
SS1
SUN SILVER LIMITED
Gerard O'Donovan, Executive Director
Gerard O'Donovan
Executive Director
SPONSORED BY The Market Online